N. M. Mulet Margalef
AuthID: R-00J-2B7
1
TÃTULO: Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regoraferab (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC)
AUTORES: Argiles, G; Mulet Margalef, NM; Valladares Ayerbes, M; Vieitez de Prado, JV; Gravalos, C; Garcia Alfonso, PG; Santos, C; Tobena, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Rodriguez Garrote, MR; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E;
PUBLICAÇÃO: 2019, FONTE: European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in ANNALS OF ONCOLOGY, VOLUME: 30
AUTORES: Argiles, G; Mulet Margalef, NM; Valladares Ayerbes, M; Vieitez de Prado, JV; Gravalos, C; Garcia Alfonso, PG; Santos, C; Tobena, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Rodriguez Garrote, MR; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E;
PUBLICAÇÃO: 2019, FONTE: European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in ANNALS OF ONCOLOGY, VOLUME: 30
INDEXADO EM: 
WOS
WOS